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“Evaluation of Knowledge Regarding Diagnostic Strategies for Genetic Diseases in 
Select Residents” 
Publication No. ____ 
Samantha J. Penney, B.A. 
Supervisory Professor: Sarah J. Noblin, M.S. C.G.C. 
 
Genetics education for physicians has been a popular publication topic in the 
United States and in Europe for over 20 years. Decreasing numbers of medical 
genetics professionals and an increasing volume of genetic information has created a 
dire need for increased genetics training in medical school and in clinical practice. This 
study aimed to assess how well pediatrics-focused primary care physicians apply their 
general genetics knowledge to clinical genetic testing using scenario-based questions. 
We chose to specifically focus on knowledge of the diagnostic applicability of 
Chromosomal Microarray (CMA) technology in pediatrics because of its recent 
recommendation by the International Standard Cytogenomic Array (ISCA) Consortium 
as a first-tier genetic test for individuals with developmental disabilities and/or 
congenital anomalies. Proficiency in ordering baseline genetic testing was evaluated for 
eighty-one respondents from four pediatrics-focused residencies (categorical 
pediatrics, pediatric neurology, internal medicine/pediatrics, and family practice) at two 
large residency programs in Houston, Texas. Similar to other studies, we found an 
overall deficit of genetic testing knowledge, especially among family practice residents. 
Interestingly, residents who elected to complete a genetics rotation in medical school 
scored significantly better than expected, as well as better than residents who did not 
elect to complete a genetics rotation. We suspect that the insufficient knowledge 
among physicians regarding a baseline genetics work-up is leading to redundant (i.e. 
concurrent karyotype and CMA) and incorrect (i.e. ordering CMA to detect 
achondroplasia) genetic testing and is contributing to rising health care costs in the 
United States. Our results provide specific teaching points upon which medical schools 
can focus education about clinical genetic testing and suggest that increased 
collaboration between primary care physicians and genetics professionals could benefit 
patient health care overall.  
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Background 
 
The field of genetics is rapidly expanding, resulting in an increasing number of 
genetic tests available for clinical application. It has been predicted that primary care 
providers will feel an increased demand to provide information on these newly available 
genetic tests and their results [1,2,3,4]. Once born, a child first comes into contact with 
the health care system through his/her primary care provider (PCP). It is known that 3-
5% of all children are born with a birth defect [5] and sometimes these birth defects can 
indicate an underlying genetic condition which should be diagnosed quickly and 
accurately. A child’s pediatrician should refer them to a genetics specialist if a genetic 
etiology is suspected. Once a patient arrives in a pediatric genetics clinic, an accurate 
diagnosis is the desired end-point so that families will have correct information about 
the prognosis, potential treatments and recurrence risk.   
 
We have seen, through our experiences at Children’s Memorial Hermann 
Hospital and Lyndon B. Johnson General Hospital, both in Houston, Texas, that 
children and adolescents are commonly referred to our genetics clinic upon suspicion 
of genetic disorders such as Neurofibromatosis type I and Marfan syndrome.  However, 
many of these children have had no work up at all prior to their referral. Patients are 
also referred with a confirmed diagnosis of Down syndrome, for example, only to find 
out that they were diagnosed using CMA, when a karyotype is still the ‘gold standard’ 
for diagnosis [6].  
 
We propose that diagnosis using non-ideal methods is in part due to a lack of 
adequate training in genetics in medical schools and pediatrics-based residency 
programs.  There have been several studies performed in the United States, as well as 
in Europe and Canada, looking at physicians’ knowledge of genetics (i.e. inheritance 
patterns of genetic condition, knowledge about screening for genetic conditions) 
[7,8,9,10,11,12]. These studies have consistently shown a deficit in knowledge. Many 
of these studies have focused on cancer genetics knowledge, with few studies focusing 
on primary care physicians’ (PCP) knowledge of which genetic tests are most 
appropriate in a clinical pediatrics setting.  
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Thus, in the current study, we aimed to assess how knowledgeable pediatrics-
focused residents are about clinical testing, including chromosomal microarray (CMA), 
in order to highlight specific areas for which current medical school and residency 
program curricula can be improved. Such improvements will enable physicians to 
become more comfortable ordering first-tier genetic testing, expedite time to diagnosis 
and decrease the unnecessary spending of health care dollars by patients and 
insurance companies.  
 
Since the Human Genome Project’s contribution to the knowledge of genetic 
causes of human diseases, genetics has become a more frequent topic of discussion in 
mainstream medicine [2]. In less than 10 years since the completion of the project, 
whole exome sequencing has become clinically available [13]. Now, the thousands of 
genes in the human genome can be analyzed, often at a lower cost than individual 
gene analysis. In addition, the rise in popularity of direct-to-consumer (DTC) genetic 
testing in 2007 [14] has enabled patients to receive personalized genetic testing results 
without first consulting with their doctor, leaving PCPs and other medical professionals 
to retroactively interpret the results. Two studies performed in the United States found 
that 15-19% of PCPs have had at least one patient come to an appointment with 
questions about personal genomic testing results, that were ordered directly from a 
DTC company [15,16].  Additionally, the majority of patients who have had DTC testing 
expect that their doctors will be conversant enough in genetics to be able to explain 
and interpret the results of that testing [17].  
 
Insufficient Genetics Workforce 
Typically, genetic testing, like whole exome sequencing and chromosomal 
microarray analysis, is ordered by medical geneticists; however the current workforce 
of genetics professionals is not able to meet demand. The Royal College of Physicians 
estimated that for every 250,000 people, one full-time geneticist is required [18]. From 
this report, it has been extrapolated that the United States requires 1,232 full time 
clinical geneticists for adequate population coverage [19]. According to the American 
Board of Medical Genetics (ABMG), there are currently a sufficient number of clinical 
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geneticists to support our population; however the number of clinical geneticists 
receiving board certification per year has decreased over the last 30 years [20]. 
Additionally, according to the ABMG 2003 survey of certified geneticists, the majority of 
clinical geneticists in the United States and in Canada report their practices as nearly 
full or full, with a little over half being able to accept a new patient within three weeks 
[21,22]. When stratified by subgroup, half of pediatric geneticists have new patient wait 
times of up to 3 months and only 5% of pediatric geneticists can see a new patient 
within one week [23]. Furthermore, 60% of the geneticists surveyed by ABMG feel that 
the demand for geneticists exceeds the supply. As a follow up to ABMG’s 2003 study of 
the genetics workforce, Cooksey et al., showed that 41% of patients seen by pediatric 
geneticists require more than one visit to complete a diagnostic evaluation [23].  In 
order to make the best use of the limited resource of a clinical genetics visit, PCPs 
could consider ordering first-tier testing so that the results will be available when the 
patient visits a genetics clinic for the first time. 
 
Genetic Testing 
A genetics work-up often includes evaluation of a patient for specific clinical 
features (e.g. a heart defect or abnormal skin pigmentation) as well as molecular 
genetic testing. For the purposes of this study, ‘first-tier’ or baseline testing for clinically-
diagnosable genetic conditions aims to rule in or rule out pathognomonic or diagnostic 
criteria (i.e. Lisch nodules in a patient with suspected Neurofibromatosis type I). 
Baseline molecular testing includes methodologies such as single gene analysis, 
karyotype, and Chromosomal Microarray (CMA). Baseline molecular testing also 
includes methodologies outlined by consensus recommendations. For example, The 
American College of Medical Genetics (ACMG) currently recommends a 23-mutation 
panel for use in general population screening for cystic fibrosis [24]. Additionally, the 
American College of Obstetrics and Gynecology (ACOG) issued a consensus 
statement in 2011 stating that complete sequencing of the entire CFTR gene that is 
known to cause cystic fibrosis is never appropriate for carrier screening due to the risk 
of receiving difficult-to-interpret results [25]. Similar statements exist for several of the 
conditions, such as Fragile X and phenylketonuria, that were chosen as the focus of the 
current study [26,27].   
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Specific attention should be paid to the ACMG’s recently published guidelines 
for use of array-based technology [28] as well as the International Standard 
Cytogenomic Array (ISCA) Consortium’s recommendation of array-CGH (chromosomal 
microarray, CMA) as a first-tier clinical diagnostic test for persons with unexplained 
developmental disability, autism spectrum disorders, or multiple congenital anomalies 
[29].  When CMAs were first ordered for the evaluation of microdeletions and 
microduplications in a patient, a standard karyotype was often concurrently ordered. 
Today, it is recognized that with the exception of CMA’s inability to detect balanced 
translocations, karyotypes are redundant testing when ordered alongside a CMA. On 
the other hand, CMAs do not detect point mutations or trinucleotide repeat mutations 
responsible for the majority of genetic disorders like achondroplasia and Fragile X, 
respectively.  Our experience has been that many health care providers are still 
ordering a CMA and karyotype together, or are ordering a CMA for single gene 
disorders, like achondroplasia, that it cannot detect.  For this reason, we chose to 
emphasize CMAs in our study.  
 
Primary Care Providers as Gatekeepers 
Primary care providers have first contact with undiagnosed patients and are 
responsible for continuing to care for patients once they receive a diagnosis.  Thus, it 
has been proposed that PCPs act as gatekeepers to specialists such as medical 
geneticists [30,31]. Without supplanting the role of genetics professionals, it is crucial to 
educate PCPs about baseline genetic testing that can be completed prior to a genetics 
consultation if they are to take on a more active gatekeeper role.  Many children are 
referred to our genetics service with little to no previous work up, meaning they must be 
seen multiple times before a diagnosis is achieved. This increases the overall cost to 
families.  
 
Health Care Costs 
The case scenarios in our study ask residents to choose the next most 
appropriate first-tier genetic test/clinical action in conjunction with a referral to a 
genetics specialist. There are several genetic testing methodologies that can give a 
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correct diagnosis; however, it would be prudent for physicians to know the 
methodologies that give the maximum information in the most straight-forward manner 
for medical management, recurrence risk, and for cost savings purposes. 
  
Many genetic diagnoses can be established by both direct and indirect methods.  
Obviously, the most direct method early in an individual’s evaluation will lead to a 
reduction in health care costs.  In 2009, health care spending in the United States was 
the highest of all industrialized countries, totaling $2.5 trillion dollars or 17.6% of the 
nation’s Gross Domestic Product (GDP) [32]. Certainly this cost is driven up by 
duplicate and redundant genetic testing. A case example that we focused on with the 
current study is the diagnosis of Down syndrome. Students learn through 
undergraduate genetics courses and/or in medical school that Down syndrome is 
caused by extra material from chromosome 21. Ninety-five percent of cases of Down 
syndrome are caused by the sporadic occurrence of an extra chromosome 21 and 3-
4% of cases are caused by a translocation involving an extra chromosome 21. 
Additionally, 1-2% of cases are due to mosaicism [33]. Each genetic cause of Down 
syndrome has a different recurrence risk [34]. The ‘gold-standard’ for diagnosis of  any 
aneuploidy, including Down syndrome, is through standard karyotype, enabling 
differentiation between a free trisomy, a translocation, and mosaicism [6]. There are 
other genetic testing methodologies, such as fluorescence in-situ hybridization (FISH) 
or CMA that can be used to make the suspected diagnosis because both confirm the 
presence of extra material from chromosome 21. However, neither FISH nor a CMA 
can determine whether the extra chromosome 21 material is from a free trisomy or a 
translocation [35]. While medical management can be carried out based on FISH or 
CMA results, the American Academy of Pediatrics recommends that a positive FISH 
result be confirmed with a karyotype [33].  
 
In summary, there are many methods to determine a diagnosis of Down 
syndrome, but a karyotype is recommended because it gives the most complete 
information necessary for accurate characterization of recurrence risk. We specifically 
included this scenario in our study in order to investigate whether residents are 
mistakenly ordering incorrect or redundant testing for Down syndrome. There are 
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several other situations for which redundant testing is frequently ordered so the 
discussion of Down syndrome can be extrapolated to those as well. 
 
Medical School and Resident Education 
To combat increasing health care spending on genetic testing, PCPs must 
receive more education about genetic testing in medical school and in residency. 
Several taskforce and work group investigations [4,36,37]  have explored the idea that 
medical schools and residency programs are not preparing PCPs to provide genetic 
services and information to their patients. While there are numerous articles touting the 
lack of and need for genetics education in medical schools and residency programs in 
the U.S. [38], there are recognized obstacles to integrating genetics into medical school 
and residency program curricula. These obstacles include: a crowded curriculum, lack 
of knowledgeable faculty, a disconnect between basic sciences and clinical 
experiences during training, failure to integrate genetics across the curriculum, 
inadequate representation of genetics on certifying exams, and lack of management 
and referral guidelines in genetics [39].  
 
The Accreditation Council for Graduate Medical Education (ACGME) is 
responsible for releasing guidelines by which medical residencies must structure their 
residency programs. According to ACGME guidelines[40], pediatric residents must 
complete seven months of subspecialty training and have the option to rotate through 
genetics among other choices. Thus, at the residency level, genetics is not a required 
rotation in pediatrics. Additionally, according to ACGME guidelines, genetics is an 
optional area of study in pediatric neurology and is not mentioned in the guidelines for 
family practice or pediatric internal medicine residencies [41,42,43].  Without proper 
training, pediatric-focused PCPs will not be familiar with the appropriate use of basic 
clinical genetic testing such as karyotypes, FISH, microarray and other molecular 
testing to evaluate pediatric genetic syndromes.  
 
In order to prepare graduating medical students for applying genetics 
information to their patients’ conditions, medical schools should focus on teaching the 
clinical application of genetics in addition to basic genetics information including 
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inheritance patterns. The University of Texas Medical School at Houston (UT) does 
require their students to take genetics in medical school, although the course is not a 
semester-long course like many others.  Furthermore, genetics is a required two-week 
rotation in the pediatrics residency program at UT [44].  There are other medical 
schools, like Baylor College of Medicine, that are beginning to offer special programs or 
‘tracks’ to students interested in genetics. These programs are working to incorporate 
more genetics into the curriculum for everyone else, too [45,46]. Restructuring medical 
school curriculum as these programs have done shows potential to integrate more 
training in genetics into medicine. 
 
Originally, research showed that not only did primary care providers have 
inadequate genetics education and knowledge, but that they were also reluctant to 
remedy this problem [47]. However, more recent studies have found that PCPs 
acknowledge a need to increase their genetics knowledge [36,48]. Several strategies to 
address these issues have been proposed by PCPs and clinical genetics professionals. 
These include Continuing Medical Education (CME) courses, lectures, case-based 
educational material that can be integrated into residency training programs and short 
internships with genetics professionals. Each solution has advantages and 
disadvantages that should be explored in order to best suit the needs of PCPs at all 
levels of training.  
 
Many diseases have a genetic component; as such, it is important for most 
medical specialties to have some working knowledge of how disease is influenced by 
genetics. While most children enter a genetics clinic through a referral from their PCP, 
there must be a balance between under and overeducating these generalists about 
genetics. Since PCPs do not seem to be adequately educated in the clinical application 
of genetic testing, how should they proceed when caring for their patients with a 
suspected genetic disease? Essentially, there are two choices: one, PCPs could order 
no genetic testing and refer all patients with suspected genetic conditions to medical 
geneticists. Alternatively, PCPs could continue as they have been, ordering genetic 
tests in conjunction with a referral to a medical geneticist. There are advantages and 
disadvantages to both approaches that can be considered separately. 
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Even in the first scenario where PCPs order no genetic testing but refer instead 
to a medical geneticist, there is a certain level of basic genetics knowledge needed for 
PCPs to identify patients who might benefit from such a consult. In this case, a PCP 
would need to recognize facial and/or body features that might characterize a genetic 
syndrome. The strategy of referring patients for a genetics consultation will ensure that 
genetic testing is only ordered by the ‘experts’, an ideal solution if one only cares to 
decrease wasteful healthcare spending. However, this strategy will likely necessitate 
more visits with the genetics team before a diagnosis is reached, placing extra strain on 
genetics clinics that currently have new-appointment wait times of 3 months or longer 
[23]. The first visit for these patients will entail an evaluation with ordering of preliminary 
tests and subsequent visits will be needed for interpretation of the first round of genetic 
testing and the addition of second-tier testing, when necessary. A problem with the 
approach outlined above is aforementioned insufficiency of the genetics workforce, 
such that we will be unable to meet future demands of the population. Furthermore, 
Huang et al., (2002) found that for children with Williams syndrome, an earlier 
diagnosis reduced the number of tests necessary for the child’s medical care. This 
decrease in cost is likely due in part to the specific health care guidelines that exist for 
children with Williams syndrome that allow their medical care to be extremely focused 
[49]. Reaching a diagnosis in the fewest visits possible is likely to reduce financial 
burdens on families with children who have genetic conditions. 
 
Alternatively, PCPs could continue ordering genetic testing to the best of their 
abilities in conjunction with a referral to a genetics specialist. There is evidence, 
however, that this approach is resulting in increased health care-related costs. ARUP 
laboratories found that over an eleven-month period in 2010, genetic counselors 
employed by their laboratory identified and cancelled or changed inappropriately 
ordered genetic tests, totaling an average of $36,500 per month [50]. Certainly, some 
of this ordering error could be due to unfamiliarity with test requisition forms, which 
often vary between laboratories. Additionally, it is not possible to tell if the doctor filled 
out the requisition form or if it was filled out by a nurse or other employee. Thus, it is 
conceivable that the correct test was requested by the doctor, but marked incorrectly 
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on the requisition form by another individual. ARUP also found that 17% of misordered 
tests were for a cystic fibrosis panel with reflex to full sequencing of the cystic fibrosis 
gene, CFTR. While rare in comparison to many indications for which a child might see 
a PCP, cystic fibrosis is a common genetic condition among individuals of Caucasian 
descent, with an incidence of 1 in 2,500. Cystic fibrosis is caused by homozygous 
mutations in the cystic fibrosis transmembrane conductance regulator protein (Cftr) 
encoded by the CFTR gene. One mutation is inherited from each parent that prevents 
the Cftr protein from working correctly leading to a buildup of mucus in the lungs, 
gastrointestinal, and pancreas of affected patients [51]. Among non-Hispanic 
Caucasians, 88% of mutations responsible for cystic fibrosis are detected by the 25-
common mutation panel recommended by The American College of Medical Genetics 
(ACMG) [51]. The detection rate is higher among Ashkenazi Jews and lower among 
individuals of African American or Hispanic American descent. Thus, for most 
individuals of Ashkenazi Jewish or non-Hispanic Caucasian descent, the common 
mutation panel, that costs $210 [52], is appropriate and adequately detects most 
common mutations responsible for cystic fibrosis. In an individual of Hispanic American 
descent, a healthcare provider might consider ordering full sequencing of the CFTR 
gene to bring the detection rate for mutations up from 57% to 98.7%. The cost of full 
sequencing however is $1,870. The difference between a common mutation panel and 
full sequencing might be difficult to appreciate without sufficient background knowledge 
of genetic testing methodologies and differences in carrier frequencies among various 
ethnic groups. If PCPs continue to order genetic testing for cystic fibrosis, they must be 
educated on the suitability of different testing methodologies for different ethnic groups 
to ensure that ordering of wasteful genetic testing is decreased.  
 
Because it has been suggested by focus groups that case-based genetics 
education might be a helpful tool to increase knowledge of genetics and genetic testing 
in primary care [48], the current study aimed to evaluate current knowledge in a subset 
of pediatric-focused medical residents when given hypothetical clinical scenarios. 
These scenarios were designed to be representative of common clinical situations that 
might be encountered by a generalist working with children. We aimed to identify 
weaknesses, if present, in the current state of clinical genetics testing knowledge as 
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part of an overall movement to increase the quality of medical services available to the 
pediatric population.  
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Materials and Methods 
 
Study Design 
The survey-based study was designed to assess the knowledge of first-tier 
genetic testing among pediatric-focused residents since these are the specialties most 
likely to encounter a child with an undiagnosed genetic condition. A survey of case-
based scenarios was used to assess the current working knowledge of medical 
residents at The University of Texas Medical School at Houston (UT) and Baylor 
College of Medicine in four different pediatric-focused residencies. Demographic 
information was also obtained on the responders. Comparisons were made between 
residency programs, residency specialties, year of residency, and prior experience and 
education. We hypothesized that all residents would have a deficit of knowledge with 
regard to ordering genetic testing as part of a baseline genetics work-up.  
 
Study Population 
Residents were recruited for this study from the following pediatric-focused 
specialties:  Categorical Pediatrics, Medicine/Pediatrics (Med/Peds), Pediatric 
Neurology (Pedi Neuro), and Family Practice. Residents were recruited from all years 
of residency. Participating institutions were The University of Texas Medical School at 
Houston (UT) and Baylor College of Medicine (BCM), both in Houston, Texas.  
 
Residents were invited to participate in the study by a series of emails sent over 
a 4-month period. Data collection was initiated on November 21, 2011, and completed 
on March 23, 2012.  The emails were sent to the residents by their program directors 
and no identifying information was made available to the primary investigator and 
committee. The emails included a link to the survey in SurveyMonkey® (Appendix A). 
 
The study was educational in nature, thus it was considered exempt by the 
Institutional Review Boards (IRBs) at UT (HSC-MS-11-0574) and BCM (H29897). As 
required by the IRB process, the email sent to the residents included the purpose of the 
study along with information on the voluntary and anonymous nature of their 
participation in the study. This information was repeated on the first page of the survey 
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and participants were asked to consent by clicking that they understood (Appendix B). 
There was no financial incentive offered for completion of the survey.  
 
The questionnaire included 33 items assessing general demographic 
information, previous experience with genetics, and prior education, as well as 15 
scenario-based questions to assess genetic testing knowledge. Most of the 
demographic information was collected using multiple choice questions; however, 
some questions provided areas for free response. Additionally, respondents were given 
the opportunity to enter comments about the survey upon completion.  Each scenario-
based question focused on one genetic condition. The genetic conditions were chosen 
based on those that are commonly seen in genetics clinic as well as on genetic 
conditions that residents must be familiar with in order to pass their board examinations 
[53]. The questions were written by the primary investigator and reviewed by the 
committee. An answer was deemed correct by the investigating committee based on 
their experience and recommendations from various professional organizations and 
websites (e.g. ACMG and GeneTests.org). The study did not aim to assess residents’ 
ability to recall a genetic condition based on clinical features. Thus, for some scenarios, 
the question provided the residents with the suspected diagnosis, enabling them to 
focus on choosing only the genetic testing needed to confirm the particular diagnosis, 
as opposed to unnecessarily ordering a full work-up. 
 
 For all genetic tests in the survey, prices charged to insurance companies were 
obtained from the clinical laboratories, hospital, or clinic that offers the tests (Appendix 
C). When insurance pricing was not available, institutional prices were used. Price 
information was obtained from the following laboratories, hospitals, and/or clinics: 
Baylor College of Medicine Medical Genetics Laboratories in Houston, TX; Children’s 
Memorial Hermann Hospital in Houston, TX; City of Hope Molecular Diagnostic 
Laboratory in Duarte, CA; Esoterix, Inc. in Austin, TX; Fisher Scientific 
(http://www.fishersci.com); Greenwood Genetic Center in Greenwood, SC;  Robert 
Cizik Eye Clinic in Houston, TX; The Ohio State University Medical Center in 
Columbus, OH; and the University of Oklahoma Health Sciences Center Genetics 
Laboratory in Oklahoma City, OK. It was assumed that for each hypothetical patient 
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scenario, correct genetic testing would have eventually been ordered, even if not a by 
the primary care provider. Thus, in order to assess the total cost of diagnosis for the 
hypothetical patient, the price of the correct genetic test was added to all incorrect 
answer options that did not already include the correct test. Cost analysis was 
performed for select questions comparing residents who responded correctly to those 
who responded incorrectly. 
  
 
Statistical Analysis 
Data collected from SurveyMonkey® was exported to Microsoft® Excel and then 
into STATA®10 (STATA Corporation, College Station, TX) for analysis. All data was 
analyzed using p values that were significant if < 0.05. Percent score was calculated as 
the number of questions each respondent got correct out of the total number they 
answered, regardless of whether they answered all questions. For variables comprised 
of two groups, t-tests were run to test for significance of effect on overall percent score 
(H0 = mean percent score is the same for both groups). For variables comprised of 
more than two groups, classical one-way ANOVA was run to test for significance of 
effect on overall percent score (H0= mean percent score is the same for all groups) with 
posthoc Tukey tests to identify which group was different, if any. Additionally, percent 
score was compared between those residents who answered only the first five 
questions and those residents who answered more than five questions, between 
residency programs, and between residency specialties. Variables found to be 
significant by univariate analysis were analyzed using linear regression when 
appropriate, then examined with multivariate analysis. 
 
Three members of the committee and one outside genetics professional 
assigned each scenario-based question a value for the expected percentage of 
residents that should correctly answer the question (expected correct rate). The values 
were assigned between 0% and 100% in 25% increments. To prevent bias, expected 
correct rates were determined before these individuals had seen the results of the 
study. Subsequent analysis of expected correct rates showed raters to be in ‘fair’ 
agreement based on Interpretation of Kappa adapted by Viera and Garrett (2005) [54] 
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(kappa statistic = 0.35). An average of these values (average expected correct rate) 
was used to run a binomial probability test to determine whether the observed correct 
rate differed significantly from the expected correct rate.  
 
For each scenario-based question, several variables were tested with chi2 for 
association with percent score overall and with correct answer rates per individual 
question. These variables included general demographics, information about current 
residency program, educational history, and about residents’ families such as the 
number of children they have and whether anyone in their family had ever been 
diagnosed with a genetic condition.  See Appendix D for a complete listing of variables. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   15 
 
Results 
 
General Demographics and Response Rates 
Table 1 summarizes the study population stratified by residency program, 
residency year, and specialty. At UT, the majority of eligible participants were residents 
in categorical pediatrics (48.9%, 68 of 139), followed by family practice (25.9%, 36 of 
139), medicine/pediatrics (16.5%, 23 of 139), and pediatric neurology (8.6%, 12 of 
139). At BCM, the majority of eligible participants were also residents in categorical 
pediatrics (75.0%, 111 of 148), followed by medicine/pediatrics (20.9%, 31 of 148), 
then pediatric neurology (4.1%, 6 of 148). Residents from the BCM family practice 
program never received the invitation to participate in the study. Overall, the majority of 
eligible participants were residents in categorical pediatrics (62.4%, 179 of 287), 
followed by medicine/pediatrics (18.8% 54 of 287), then family practice (12.5%, 36 of 
287), and finally pediatric neurology (6.3%, 18 of 287). 
 
Of the 287 residents that were eligible to participate in the study, we received 
responses from 106 individuals giving us a 36.9% percent response rate. Nineteen 
respondents were excluded from analysis because they did not answer any scenario 
questions, resulting in a total of 87 respondents. Among the 87 respondents, six more 
were excluded because they were either not in one of the four residencies examined by 
this study, no longer in a residency program, or not affiliated with BCM or UT. The final 
number of respondents analyzed was 81 (28.2% response rate). 
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Table 1: Study Population Stratified by Residency Program, Residency Year, & 
Residency Specialty 
 
Program  Year Pediatrics Medicine/Pediatrics 
Pediatric 
Neurology 
Family 
Practice  
  
PGY-1 22 6 2 12   
PGY-2 20 4 3 12   
PGY-3 26 6 3 12   
PGY-4 0 7 3 0   
PGY-5 0 0 1 0  
UT 
  68 23 12 36 139 
PGY-1 36 8 5 n/a   
PGY-2 35 8 3 n/a   
PGY-3 40 8 0 n/a   
PGY-4 0 7 0 n/a   
BCM 
  111 31 8 n/a 150 
Totals   179 54 20 36 289 
 
Table 2 summarizes general demographic information of respondents. The 
majority (72.8%, n=59) were female, in residency at UT (63.0%, n=51), and had 
attended medical school in the United States (82.7%, n=67). In addition, the majority of 
respondents (60.5%, n=49) were younger than 30 years of age.  For demographic 
information collected by free response, investigators analyzed data in groups created 
after the collection of data was complete (i.e. undergraduate majors were grouped into 
‘Biology/Health, Other Science, and Liberal Arts categories). When more than one 
major or minor was listed, respondents were grouped using whichever major or minor 
theoretically would have given them more instruction in genetics. Most respondents 
(55.6%, n = 45) majored in a Biology/Health field at their undergraduate institution (e.g. 
biology, biomedical science, biology and molecular genetics). Most respondents 
(65.0%, n=53) did not complete a genetics rotation in medical school, although eight 
respondents (10.0%) elected to complete a genetics rotation in medical school even 
though it was not required.  
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Table 2: General Demographic Information of Respondents 
 
Sex Number % 
Male 21 25.9 
Female 59 72.8 
No response 1 1.2 
Age   
Younger than 30 years 49 60.5 
30-34 years 19 23.5 
Older than 34 years 13 16.1 
Residency Program   
UT 51 63.0 
BCM 30 37.0 
Attended  Medical School in the US   
Yes 67 82.7 
No 14 17.3 
Post-call on day of survey   
Yes 11 13.6 
No 70 86.4 
Undergraduate Major   
Biology/Health 45 55.6 
Other Science 12 14.8 
Liberal Arts 18 22.3 
No response 6 7.4 
Undergraduate Minor   
Biology/Health 6 7.4 
Other Science 12 14.8 
Liberal Arts 14 17.3 
No response/No minor 49 60.5 
Nature of Genetics Rotation in Medical School   
Elective 8 10 
No Rotation 53 65.0 
No Response 12 25.0 
Total 81  
 
Table 3 summarizes residency information for the 81 respondents analyzed in 
this study.  Most responders were categorical pediatrics residents (63.0%, n=51), 
followed by family practice (18.5%, n=15), medicine/pediatrics (12.3%, n=10), and 
finally pediatric neurology (6.17%, n=5). Except for family practice, roughly equal 
numbers of responses were received from UT and BCM in each specialty. For UT and 
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BCM, most residents were from categorical pediatrics (n=28 and n=23, respectively). 
The fewest responders were from pediatric neurology (n=3 and n=2, respectively). 
 
Table 3: Summary of Number of Respondents by Residency Specialty, Year, and 
Medical School Affiliation 
 
Program Year Pediatrics Medicine/Pediatrics 
Family 
Practice 
Pediatric 
Neurology  
PGY-1 8 2 8 1  
PGY-2 10 1 4 1  
PGY-3 10 2 3 0  
PGY-4 0 0 n/a 0  
PGY-5 0 n/a n/a 1  
UT 
Total 28 5 15 3 51 
PGY-1 10 2 n/a 1  
PGY-2 4 2 n/a 1  
PGY-3 8 1 n/a 0  
PGY-4 1 0 n/a 0  
BCM 
Total 23 5 n/a 2 30 
Totals  51 10 15 5 81 
 
 
Table 4 shows response rate by residency year stratified by residency program. 
The overall response rate for the study was 28% (81/287). The response rate was 
higher for UT than for BCM (35% vs. 20%) and the response rate was highest among 
residents in the UT family practice and categorical pediatrics residency programs (42% 
and 41%, respectively). 
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Table 4: Response Rates by Residency Year Stratified by Residency Program  
 
Program Year Pediatrics 
Medicine/
Pediatrics 
Family 
Practice 
Pediatric 
Neurology 
 
PGY-1 36% 33% 67% 50%  
PGY-2 50% 25% 33% 33%  
PGY-3 38% 33% 25 0%  
PGY-4 n/a 0% n/a 0%  
PGY-5 n/a n/a n/a 100%  
UT 
Total 41% 22% 42% 37% 35% 
PGY-1 27% 25% n/a 25%  
PGY-2 12% 25% n/a 50%  
PGY-3 20% 13% n/a n/a  
PGY-4 n/a 0% n/a n/a  
BCM 
Total 20% 21% n/a 19% 20% 
Totals  31% 21% 42% 28% 28% 
 
 
Case-Based Scenario Questions  
Each scenario was given an expected percent correct rate by the investigators. 
Because not all respondents completed the entire survey, tables 5, 6, and 7 show 
summaries of responses by each page of scenario questions. The tables include 
correct answers, expected and observed correct answer rate, and whether the 
difference between expected and observed correct answer rate was statistically 
significant. The correct answer for each question is italicized.  
 
The observed correct rates were significantly lower than expected for the 
scenarios involving Fragile X syndrome, Down syndrome, carrier screening for cystic 
fibrosis, Spinal Muscular Atrophy, multiple congenital anomalies, Turner syndrome, 
PKU and achondroplasia, (p<0.05). The observed correct rates for the scenarios 
diagnosing suspected CF and Marfan syndrome were lower than expected, although 
not statistically significant. Interestingly, the observed correct rate was higher than 
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expected for scenarios involving ambiguous genitalia, Prader Willi syndrome, Noonan 
syndrome, unspecified hemoglobinopathy, and Neurofibromatosis type I, although 
these values were not statistically significant.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   21 
 
Table 5: Observed and Expected Correct Answer rates for Questions 1-5 
Q1: Ambiguous Genitalia Freq. % 
Expected 
Correct 
Rate 
P 
value 
CMA only 0 0.0%   
CMA + Karyotype 6 7.4%   
CAH biochemical screen 8 9.9%   
CAH biochemical screen + Karyotype 47 58.0% 56.3% 0.666 
CAH biochemical screen + Karyotype + 
CMA 20 24.7%   
     Q2: Fragile X     
CMA only 5 6.2%   
CMA + Fragile X testing 30 37.0%   
CMA + Fragile X testing + karyotype 15 18.5%   
CMA + karyotype 2 2.5%   
Fragile X testing only 29 35.8% 57.5% <0.001 
     Q3: Down syndrome     
CMA only 8 9.9%   
FISH for chromosome 21 19 23.5%   
Karyotype only 24 29.6% 62.5% <0.001 
CMA + FISH for chromosome 21 22 27.2%   
CMA + Karyotype 8 9.9%   
     Q4: New baby suspected CF     
CFTR deletion testing 9 11.1%   
CFTR full sequencing 7 8.6%   
CFTR mutation panel 47 58.0% 57.5% 0.580 
CMA 4 4.9%   
CMA + CFTR mutation panel 14 17.3%   
     Q5: CF screening with known 
mutation in a partner     
CFTR deletion testing 3 3.7%   
CFTR sequencing 17 21.0%   
Targeted CFTR for deltaF508 25 30.9%   
CFTR mutation panel 33 40.7% 51.3% 0.037 
CMA 3 3.7%   
Total (for each question) 81    
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Table 6: Observed and Expected Correct Answer Rates for Questions 6-10 
Q6: SMA Freq. % 
Expected 
Correct 
Rate 
P 
value 
Deletion/Duplication testing SMN1 27 37.5%   
CMA 21 29.2%   
Sequencing of SMN1 (all exons) 13 18.1%   
Sequencing of SMN1 (exons 7 and 8 only) 7 9.7%   
Deletion/Duplication SMN1 (exons 7 and 
8) 4 5.6% 26.3% <0.001 
     
Q7: Prader Willi syndrome     
CMA 12 16.7%   
FISH for PWS critical region 14 19.4%   
Methylation studies of PWS critical region 24 33.3% 32.5% 0.614 
Sequencing of SNRPN 4 5.6%   
UPD testing for PWS critical region 18 25.0%   
     
Q8: Multiple congenital anomalies of 
unknown etiology     
CMA 40 55.6% 75.0% <0.001 
Karyotype only 2 2.8%   
Fragile X testing 6 8.3%   
Metabolic work-up (PAA, UOA, ACP) 24 33.3%   
Telomere FISH 0 0.0%   
     
Q9: Turner syndrome     
CMA only 14 19.4%   
Karyotype only 36 50.0% 73.8% <0.001 
Skeletal survey 9 12.5%   
Metabolic work-up (PAA, UOA, ACP) 12 16.7%   
Telomere FISH 1 1.4%   
     
Q10: PKU     
Plasma amino acids + serum PAH 10 13.9%   
Immediately refer to metabolic center 5 6.9% 56.3% <0.001 
Sequencing of PAH and switch to low Phe 
diet 8 11.1%   
Repeat NBS and switch to low Phe diet 15 20.8%   
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Low Phe diet + plasma A.A. + repeat NBS 34 47.2%   
Total  (for each question) 72    
 
Table 7: Observed and Expected Correct Answer Rates for Questions 11-15 
Q11: Noonan syndrome Freq. % 
Expected 
Correct 
Rate 
P 
value 
CMA only 12 17.6%   
Karyotype for Noonan syndrome 18 26.5%   
Karyotype for Turner syndrome 7 10.3%   
Molecular testing for Noonan syndrome 31 45.6% 43.8% 0.667 
Molecular testing for Turner syndrome 0 0.0%   
CMA only 12 17.6%   
       Q12: Marfan syndrome     
CMA 3 4.4%   
Echocardiogram, ophthalmologic exam, 
homocystine & methionine panel 33 48.5% 51.3% 0.371 
Metabolic workup (PAA, UOA, ACP) 3 4.4%   
Echocardiogram + ophthalmologic exam 28 41.2%   
RET sequencing responsible for MEN2 1 1.5%   
     Q13: Unspecified hemoglobinopathy     
CMA 2 2.9%   
Sequencing FVIII and FIX responsible for 
hemoglobin A and B 4 5.9%   
Sequencing of HBB gene responsible for 
sickle cell 4 5.9%   
Hemoglobin electrophoresis, if not already 
done 57 83.8% 73.8% 0.983 
Order sickledex if not already done 1 1.5%   
     Q14: Achondroplasia     
CMA 15 22.1%   
Metabolic work up (PAA, UOA, ACP) 1 1.5%   
Serum calcium 3 4.4%   
Skeletal survey 43 63.2% 77.5% 0.005 
Vitamin D studies 6 8.8%   
     Q15: Neurofibromatosis type I     
Diagnose NF1 based on clinical criteria 40 58.8% 58.8% 0.551 
Diagnose NF1 after molecular testing is 
positive 13 19.1%   
Diagnose NF1 after skin biopsy studies 
are positive 12 17.6%   
CMA 3 4.4%   
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Echocardiogram 0 0.0%   
Total (for each question) 68    
 
 
Figure 1 represents the expected vs. observed score for all 15 case-based 
scenario questions. There were eight questions for which residents scored significantly 
lower than expected (as indicated with an asterisk). 
 
Figure 1: Expected vs. Observed Score by Scenario  
 
Overall Score 
Figure 2 shows the normal distribution of overall score for all respondents (n = 
81; p value for skewness = 0.996). The mean overall score was 43.0% (max score = 
80%, min score = 0%, SD = 18.9%), which was significantly lower than the expected 
mean overall score of 56.9% (p<0.00001). Table 8 shows scores for all respondents 
grouped in 20 percent intervals.  The majority of respondents received a score of < 
60%.  
Table 8: Overall Percent Score 
Score Groups % (# of respondents) 
<20% 6.17 (5) 
20-39% 30.86 (25) 
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40-59% 35.8 (29) 
60-79 22.22 (18) 
=80% 4.94 (4) 
Figure 2: Overall Percent Score – All respondents 
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There were several variables that significantly affected the observed mean 
overall score: number of pages complete, residency specialty, location of medical 
school, nature of genetics instruction in medical school, and electing to complete a 
genetics rotation in medical school.  
 
Number of Case-Based Scenario Questions Answered 
All respondents were grouped according to the number of pages of case-based 
scenario questions they answered; either 5 (Page 1 only), 10 (Page 1 and 2 only) or 15 
(all three pages). Overall, the percent score was different between these groups 
(ANOVA p value=0.0023) (Table 9). Posthoc Tukey test demonstrated a significant 
difference in mean score between those who only answered one page and those who 
completed all three pages. Additionally, linear regression model demonstrated an 
average increase of 11% in percent score for each additional page completed 
(p<0.0005). There was a significant difference in overall percent score between those 
who completed only the first page and those who completed all three pages (Table 9). 
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Table 9: Comparison Overall Score: Number of Pages Completed 
 
# Pages Complete N Mean Percent Score Std. Dev. P value* 
1 9 24.4% 19.4% 
2 4 32.5% 17.1% 
3 68 46.0% 17.5% 
0.001 
*comparing 1 page completed to 3 pages completed 
 
Figure 3 shows percent score for those who only answered the first five 
questions (N = 9, p value for skewness = 0.856, mean score = 24.4% (SD = 19.4), min 
score = 0%, max score = 60%). 
 
Figure 3: Overall Score: One Page Completed (n=9) 
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The nine individuals who answered only the first page and the four individuals 
who answered pages 1 and 2 were excluded in Figure 4, which shows the normal 
distribution of overall score for those respondents who answered all questions (n = 68; 
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p value for skewness = 0.554). The mean score for this group was 46.0% (max score = 
80%, min score = 13.3%, SD = 17.5%). 
 
Figure 4: Overall Score:  All Pages Answered (n=68) 
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Table 10 shows observed and expected percent correct rate for the first five 
scenarios for those individuals who only answered questions 1-5 compared to those 
who answered either 10 or 15 questions. Among these questions, only the new baby 
with suspected CF question showed a significant difference in correct response rate 
between these two groups (22.2% correct versus 60.3% correct, p=0.031).  However 
collectively, residents who only completed the first five questions had a significantly 
lower overall score on those questions than residents who completed all three pages 
(24.4% vs. 46.8%, p=0.024). 
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Table 10: Comparison of Score, First 5 pages: One page vs. Three pages 
complete 
 
 
Correct Answer Rate    
  n (%) 
 
All pages  
n= 68 
First Page 
Only n= 9 
P value 
Q1: Ambiguous Genitalia  
CAH biochemical screen + Karyotype 41 (60.3) 3 (33.3) 0.161 
Q2: Fragile X  
Fragile X testing only 25 (36.8%) 1 (11.1%) 0.130 
Q3: Down syndrome  
Karyotype only 21 (30.9%) 3 (33.3%) 0.883 
Q4: new baby suspected CF  
CFTR mutation panel 41 (60.3%) 2 (22.2%) 0.031 
Q5: CF screening with known 
mutation in a partner  
CFTR mutation panel 31 (45.6%) 2 (22.2%) 0.188 
Mean overall score for first five 
question 
46.8% 24.4% 0.024 
 
 
Residency Specialty  
As previously stated, the majority of the respondents (n=51) were categorical 
pediatric residents. There were approximately equal numbers of Med/Peds (n=10) and 
Family Practice residents (n=15). Pedi Neuro residents accounted for the fewest 
number of respondents (n=5). ANOVA comparing mean percent score for these four 
groups resulted in a significant difference in means (p<0.00001). Post-hoc tests 
showed that family practice residents had significantly lower mean scores than all other 
groups and that the other three groups did not differ significantly from each other. While 
all groups scored lower than expected (56.9%), overall percent score was only 
significantly lower than expected for Pediatrics and Family Practice Residencies (Table 
11). The distribution of overall score by residency specialty is illustrated in Figure 5. 
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Table 11: Comparison of Mean Score: Residency Specialty 
 
 
n 
Mean percent 
score 
Standard 
deviation 
P value 
(ANOVA) 
Pediatrics 51 47.5%* 17.7% 
Med/Peds 10 48.0% 13.6% 
Pedi Neuro 5 45.3% 28.0% 
Family Practice 15 23.1%* 8.0% 
<0.00001 
Total 81 
   
*Significantly lower than overall expected score (56.9%) 
 
Figure 5: Comparison of Mean Score: Residency Specialty 
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Residency Year  
Overall percent score was also divided into 5 groups by residency year.  One-
way ANOVA showed that percent score overall did not differ significantly by residency 
year. However, a trend of increasing percent score with increasing residency year was 
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observed. With the exception of the one PGY4 and one PGY5 residents, all scores 
were lower than expected and the scores for PGY1 and PGY2 were significantly lower 
(Table 12).  
 
Table 12: Comparison of Mean Score: Residency Year  
Residency Year N Mean score Std. Dev. P value (ANOVA) 
PGY1 32 40%* 19% 
PGY2 23 42%* 20% 
PGY3 24 47%* 17% 
PGY4 1 60% n/a 
PGY5 1 60% n/a 
0.417 
Total 81    
*Significantly lower than overall expected score (56.9%) 
 
Medical School Location – US versus Abroad 
Table 13 shows that the majority of residents attended medical school in the 
U.S. (82.7%, n=67). Fourteen residents attended medical school abroad. A t-test 
comparing the mean overall score between these two groups showed that residents 
who attended medical school in the U.S. scored significantly higher overall than those 
who attended medical school in another country (Figure 6, p<0.00001). However, a 
one-group t test comparing mean overall score for each group to the expected overall 
score showed that both groups of residents scored significantly lower than expected 
(Table 13). Figure 6 is a graphical representation of the information in Table 13. 
 
Table 13: Comparison of Mean Score: Medical School Location 
Location of Medical 
School N 
Mean 
percent 
score 
Std. Dev. P value (ANOVA) 
U.S. 67 46.7%* 18.3% 
Abroad 14 25.0%* 9.5% <0.00001 
Total 81    
*Significantly lower than expected overall (56.9) 
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Figure 6: Comparison of Mean Score Overall: Medical School Location 
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Medical School Genetics Rotation 
The majority of the respondents (n=53) reported not completing a genetics 
rotation during medical school. Eight residents reported that they elected to complete a 
genetics rotation while in medical school (n=8) while 20 residents did not provide a 
response to this question. ANOVA comparing the three groups resulted in a significant 
difference in mean overall percent score (p=0.001) (Table 14). T-tests demonstrated 
that the respondents taking an elective genetics rotation scored significantly higher 
than both other groups (p= 0.0001, elective compared to no rotation; p=0.0035, elective 
compared to no response) and that there was no significant difference in mean score 
between the no rotation and no response groups (p=0.830).  Not only did the residents 
who elected to complete a genetics rotation in medical school score significantly better 
than the other two groups, but they also scored significantly higher than expected 
overall (65.8% vs. 56.9%, p=0.045).  Overall percent scores for the residents who 
reported they did not complete an elective rotation and for those residents who did not 
provide a response were significantly lower than expected overall. Figure 7 is a 
graphical representation of the information in Table 14. 
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Table 14: Comparison of Mean Score: Nature of Medical School Genetics 
Rotation 
 
Elective Genetics 
Rotation in Medical 
School? 
N 
Mean 
percent 
score 
Std. Dev. P value (ANOVA) 
Yes 8 65.8 10.4% 
No 53 40.7* 16.5% 
No response 12 39.7* 21.9% 
0.001 
Total 81    
*Significantly lower than overall expected score (56.9%) 
Significantly higher than overall expected score 
 
Figure 7: Comparison of Mean Score:  Nature of Medical School Genetics 
Rotation 
0 20 40 60 80
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No rotation
Elective Rotation
 
 
Medical School Genetics Curriculum  
An examination of overall percent score also revealed that the 39 residents who 
received genetics in a dedicated class in medical school scored significantly higher 
than the 36 residents  who received genetics integrated across their entire curriculum 
(p=0.049). As seen in Table 15, the overall mean score for those residents who learned 
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about genetics in a dedicated class was 47.6% compared to the overall mean score of 
38.8% for those residents who learned genetics in an integrated format.  
 
Table 15: Comparison of Mean Score: Nature of Genetics Class in Medical 
School  
 
Nature of Genetics Class n Mean Score 
Std. 
Dev. P value (ANOVA) 
Dedicated Class 39 47.6* 17.4% 
Integrated Class 36 38.8* 20.8% 0.049 
Total 75    
*Significantly lower than overall expected score (56.9%) 
 
The following variables were also examined but were not found to significantly 
affect overall percent score: gender, medical school residency affiliation, whether or not 
the residents were post-call, college undergraduate major or minor, whether or not 
genetics was taken in college undergraduate, number of children or children under 5, 
family history of a genetic condition, length of medical school genetics rotation, and 
whether or not residents seek out genetics information via news stories or journal 
articles. 
 
Multivariate analysis 
The four variables which significantly affected overall score (residency specialty, 
medical school location, nature of medical school genetics class, and nature of medical 
school genetics rotation) were entered into multivariate analysis. When considered 
together, only residency specialty and nature of medical school genetics rotation 
significantly affected overall score (adjusted R-squared: 0.331). Family practice 
residents scored 19.7% lower on average (p=0.042) than categorical pediatric 
residents. The 53 residents who indicated that they did not elect to complete a genetics 
rotation scored 20.0% lower on average (p=0.002) than residents who chose to 
complete a genetics rotation in medical school.  
 
Redundant and Incorrect Testing Methodologies 
There were three scenarios in the survey that gave residents the option to 
choose redundant genetic testing – scenario 1 (ambiguous genitalia), scenario 2 
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(Fragile X), and scenario 3 (Down syndrome). Since all 81 respondents completed the 
three scenarios, there were 243 responses of any type (A, B, C, D, or E). Across all 
three scenarios, residents chose redundant genetic testing 30.0% of the time (Table 
16). 
 
Table 16: Redundant Genetic Testing Responses 
 
Scenario Redundant Answer Choices Answer 
Count 
1: Ambiguous Genitalia B. CMA + Karyotype 6 
 D. CAH biochemical screen + Karyotype 
+ CMA 
20 
   
2: Fragile X C. CMA + Fragile X testing + karyotype 15 
 D. CMA + karyotype 2 
   
3: Down syndrome D. CMA + FISH for chromosome 21 22 
 E. CMA + Karyotype 8 
Total Redundant Answers 73 
 
Additionally, seven scenarios contained answer choices that would not diagnose 
the genetic condition in question. The conditions featured in these scenarios were 
Fragile X, SMA, Noonan syndrome, Marfan syndrome, hemoglobinopathy, 
achondroplasia and NF1.  Eighty-one respondents answered scenario 2 (Fragile X), 72 
respondents answered scenario 6 (SMA), and 68 respondents answered each of the 
last five scenarios (Noonan, Marfan, hemoglobinopathy, achondroplasia and NF1), 
giving a total of 493 possible responses of any type to these questions. When totaled, 
residents ordered genetic testing using the wrong methodology 25.6% of the time 
(Table 17).  
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Table 17: Wrong Methodology Testing Responses 
 
Scenario Answer Choices Featuring Incorrect Methodology 
Answer 
Count 
CMA 5 
CMA  + Fragile X testing 30 
CMA + Fragile X testing + 
karyotype 15 2: Fragile X 
CMA + karyotype 2 
6. SMA CMA 21 
CMA only 12 
11. Noonan syndrome Karyotype for Noonan syndrome 18 
12: Marfan syndrome CMA 3 
13: Unspecified 
hemoglobinopathy CMA 2 
14: Achondroplasia CMA 15 
15: NF type I CMA 3 
Total Incorrect Methodology Answer Choices 126 
 
 
Cost Analysis 
Analysis of health care dollars was performed for select survey questions (Table 
18).  
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Table 18: Cost Analysis for Select Scenarios 
 
Scenario  Freq (%) Total Cost* ($) P value 
1. Ambiguous 
Genitalia 
Wrong Choices (A, 
B, C, & E) 34 (42.0) 2,641.75 
 Correct Choice (D) 47 (58.0) 861.75 
<0.00001 
2. Fragile X Wrong Choices (A, B, C, & D) 52 (64.2) 2,411.92 
 Correct Choice (E) 29 (35.8) 390.00 
<0.00001 
3. Down 
syndrome 
Wrong Choices (A, 
B, D, & E) 57 (70.4) 2,275.97 
 Correct Choice (C) 24 (29.6) 740.00 
<0.00001 
8. Multiple 
Congenital 
Anomalies 
Wrong Choices (B, 
C, D, & E) 32 (44.4) 2,498.63 
 Correct Choice (A) 40 (55.6) 1,780.00 
<0.00001 
* Mean total cost except Ambiguous Genitalia, where median was reported 
 
 
For all four scenarios, the average cost of diagnosis was significantly higher than 
necessary when respondents answered incorrectly. For example, in the case of Fragile 
X in scenario 2, the price of correct answer choice E, trinucleotide repeat analysis by 
DNA Southern Blot for FMR1, is $390 with a >99% detection rate. The other answer 
choices for this scenario contain either unnecessary extra testing (choice B, CMA + 
Fragile X DNA analysis) or methodologies not able to detect the condition (choice D, 
CMA +Karyotype) and all cost significantly more than $390. 
 
Variables Affecting Percent Score 
Several variables were tested as possible confounders on correct response rate 
and Table 19 lists them along with the scenarios they influenced, as indicated by an 
‘X’(p<0.05). Of the 15 scenarios, 9 had at least one variable that significantly influenced 
the observed percent correct rate. There were several variables that only affected the 
correct response rate for one scenario. Residency specialty was found to be significant 
for five of the scenarios, while location of medical school, nature of genetics rotation in 
medical school, and number of children affected the correct response rate for three 
scenarios. 
   37 
 
Table 19: Variables Affecting Correct Response Rate by Scenario 
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Sex (Male/Female)       X   
Residency Specialty X    X X X X  
Residency Year X         
Undergraduate Major         X 
Med school in the U.S. 
or abroad      X X   
Do you seek out 
genetic information 
(e.g. news stories, 
documentaries) 
     X    
Genetics class in 
undergrad  X        
Nature of genetics 
rotation in medical 
school 
  X X      
Number of children        X X 
 
 
Ambiguous Genitalia 
 
Table 20: Correct Responses (%) by Residency Specialty – Ambiguous Genitalia 
 
 Pediatrics Med/Peds Pedi Neuro Family Practice Total 
Wrong 16 (31.4) 3 (30.0) 5 (100.0) 10 (66.7) 34 (42.0) 
Correct 35 (68.6) 7 (70.0) 0 (0.0) 5 (33.3) 47 (58.0) 
Total 51 10 5 15 81 
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For scenario 1 (ambiguous genitalia), residency specialty and residency year 
significantly affected the correct answer rate. Med/Peds and categorical pediatric 
residents had the highest correct answer rates, (70% and 68.6%, respectively), while 
pediatric neurology had the lowest correct answer rate (0%) (Table 20). 
 
Table 21: Correct Responses (%) by Residency Year – Ambiguous Genitalia 
 
 PGY1 PGY2 PGY3 PGY4 PGY5 Total 
Wrong 13 (40.6) 15 (65.2) 5 (20.8) 0 (0%) 1 (100) 34 (42.0) 
Correct 19 (59.4) 8 (34.8) 19 (79.2) 1 (100) 0 (0%) 47 (58.0) 
Total 32 23 24 1 1 81 
 
Table 21 demonstrates that the correct response rate dipped initially from year 1 
of residency to year 2, but then increased through year 4. However, the correct 
response rate was 0% in year 5.   
Fragile X 
Table 22 Correct Responses (%) by Whether Genetics Was Taken in College – 
Fragile X 
 
 Yes  No  Total 
Wrong  43 (70.5) 9 (45) 52 (64.2) 
Correct  18 (29.5) 11 (55.0) 29 (35.8) 
Total 61 20 81 
 
 
Table 23 Correct Responses (%) by Number of College Genetics Classes College 
– Fragile X 
 
 No genetics 
classes 
1-2 genetics 
classes 
3-4 genetics 
classes 
Total 
Wrong  9 (45.0) 41 (70.7) 2 (66.7) 52 (64.2) 
Correct 11 (55.0) 17 (29.3) 1 (33.3) 29 (35.8) 
Total 20 58 3 81 
 
For scenario 2 (Fragile X), Table 22 shows that residents who took genetics as 
an undergraduate student (n=61) were more likely to get the question incorrect than 
those who did not take genetics during their undergraduate studies (n=20). However, 
even though it was not statistically significant, those residents who took 3-4 genetics 
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classes in college were less likely to get the question wrong than those who took 1-2 
classes (Table 23). 
 
Down syndrome  
 
Table 24: Correct Responses (%) by Nature of Medical School Genetics Rotation 
– Down syndrome 
 
 Required Elective Neither Total 
Wrong 8 (80.0) 2 (25.0) 39 (76.5) 49 (71.0%) 
Correct 2 (20.0) 6 (75.0) 12 (25.5) 20 (29.0%) 
Total 10 (100.0%) 8 (100.0%) 51 (100.0%) 69 
 
For scenario three (Down syndrome), residents who elected to  complete a 
genetics rotation in medical school were more likely to get the question correct than 
those who completed one because they were required to and those who did not 
complete one at all (Table 24). Residents who did not complete a genetics rotation 
were about as likely to get the question correct as those who completed a genetics 
rotation because they were required to (25.5% correct vs. 20.0% correct, respectively).  
 
New Baby with Suspected CF 
 
Table 25: Correct Responses (%) by Nature of Medical School Genetics Rotation 
– New Baby, Suspected CF 
 
 
Required Elective No rotation Total 
Wrong 6 (60.0) 0 (0.0) 22 (43.1) 28 (40.6) 
Correct 4 (40.0) 8 (100.0) 29 (56.9) 41 (59.4) 
Total 10 8 51 69 
 
For scenario four (new baby with suspected CF), all residents who completed an 
elective genetic rotation in medical school answered the question correctly. Residents 
in the other two categories were about as likely to get the question correct as they were 
to get it incorrect (Table 25). 
 
 
 
   40 
 
Multiple Congenital Anomalies 
 
Table 26: Correct Responses (%) by Residency Specialty - MCA 
 
 
Pediatrics Med/Peds Pedi Neuro Family Practice Total 
Wrong 15 (33.3) 4 (40.0) 2 (50.0) 11 (84.6) 32 (44.4) 
Correct 30 (66.7) 6 (60.0) 2 (50.0) 2 (15.4) 40 (55.6) 
Total 45 10 4 13 72 
 
For scenario 8 (MCA), table 26 shows that the percent correct rate was largely 
the same, ranging from  50 to 67% for all specialties except family practice, whose 
correct rate was 15.4%. 
 
Noonan syndrome 
 
Table 27: Correct Responses (%) by Residency Specialty - Noonan 
 
 
Pediatrics Med/Peds Pedi Neuro Family Practice Total 
Wrong 19 (44.2) 8 (80.0) 0 (0.0) 10 (90.9) 37 (54.4) 
Correct 24 (55.8) 2 (20.0) 4 (100.0) 1 (9.1) 31 (45.6) 
Total 43 10 4 11 68 
 
Table 27 demonstrates that for scenario 11 (Noonan syndrome), 100% of 
residents in pediatric neurology got the question correct; while family practice had the 
lowest correct rate (9.1%). Pediatrics had the second highest correct rate (55.8%) and 
med/peds had the third highest (20%).  
 
Table 28: Correct Responses (%) by Whether Medical School was Attended in the 
U.S.  - Noonan 
 
 
Medical School in the U.S. Medical School Abroad Total 
Wrong 28 (48.3) 9 (90.0) 37 (54.4) 
Correct 30 (51.7) 1 (10) 31 (45.6) 
Total 58 10 68 
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Table 29: Correct Responses (%) by Whether Residents Seek out Genetics 
Information - Noonan 
 
 
Yes No Total 
Wrong 7 (35.0) 30 (62.5) 37 (54.4) 
Correct 13 (65.0) 18 (37.5) 31 (45.6) 
Total 20 48 68 
 
Table 28 shows that the majority of residents who attended medical school 
outside of the United States answered the question about Noonan syndrome 
incorrectly, while residents who attended medical school in the United States were 
about as equally likely to answer the question incorrectly as they were to answer it 
correctly. Additionally, residents who reported that they seek out genetics information 
were more likely to get the question about Noonan syndrome testing correct than those 
who did not report this (Table 29). 
 
Unspecified Hemoglobinopathy 
Table 30: Correct Responses (%) by Gender - hemoglobinopathy 
 
 
Male Female Total 
Wrong 6 (31.6) 5 (10.4) 11 (16.4) 
Correct 13 (68.4) 43 (89.6) 56 (83.6) 
Total 19 (28.4) 48 (71.6) 67 
 
For the scenario about an unspecified hemoglobinopathy, female residents were 
more likely than males to answer correctly (Table 30).  
 
Table 31: Correct Responses (%) by Residency Specialty - hemoglobinopathy 
 
 
Pediatrics Med/Peds Pedi Neuro Family Practice Total 
Wrong 3 (7.0) 2 (20.0) 0 (0.0) 6 (54.6) 11 (16.2) 
Correct 40 (93.0) 8 (80.0) 4 (100.0) 5 (45.5) 57 (83.8) 
Total 43 (63.2) 10 (14.7) 4 (5.9) 11 (16.2) 68 
 
For scenario 13 (hemoglobinopathy), 100% of pediatric neurology residents 
answered correctly. Med/Peds and Pediatrics had similar, high correct response rates 
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(80% and 93%, respectively). Family practice residents had the lowest correct rate 
(45.5%), (Table 31). 
 
Table 32 Correct Responses (%) by Whether Medical School was Attended in the 
U.S. - Hemoglobinopathy 
 
 
Medical School 
in the U.S. 
Medical School 
Abroad 
Total 
Wrong 6 (10.3) 5 (50.0) 11 (16.2) 
Correct 52 (89.7) 6 (50.0) 57 (83.8) 
Total 57 11 68 
 
Additionally, for the hemoglobinopathy scenario, residents who went to medical 
school in the U.S. had a higher correct response rate (89.7%) than those who went to 
medical school outside of the U.S. (54.6%), as seen in Table 32.  
 
Achondroplasia 
Table 33: Correct Responses (%) by Residency Specialty - Achondroplasia 
 
 
Pediatrics Med/Peds Pedi Neuro 
Family 
Practice Total 
Wrong 15 (34.9) 2 (20.0) 0 (0.0) 8 (72.7) 25 (36.8) 
Correct 28 (65.1) 8 (80.0) 4 (100.0) 3 (27.3) 43 (63.2) 
Total 43 10 4 11 68 
 
For  scenario 14 (achondroplasia), Table 33 shows that residents in pediatric 
neurology had a 100% correct response rate, followed by med/peds (80%), then 
pediatrics (65%). Family Practice had the lowest correct response rate (27.3%).  
 
Table 34: Number of Correct Responses (%) by Number of Children - 
Achondroplasia 
 
 
No 
children 1 child 2 children Total 
Wrong 23 (45.1) 2 (25.0) 0 (0.0) 25 (36.8) 
Correct 28 (54.9) 6 (75.0) 9 (100.0) 43 (63.2) 
Total 51 8 9 68 
 
Table 34 shows that percent correct rate increased with increasing number of 
children. Respondents with 2 children (n=9) had a 100% correct response rate for the 
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scenario involving achondroplasia, while residents with no children were about equally 
as likely to answer the question correctly as incorrectly.  
 
Neurofibromatosis Type 1 
Table 35: Correct Responses (%) by Undergraduate Major – NF1 
 
 
Bio/Health Other Science Liberal Arts Total 
Wrong 10 (25.6) 9 (66.7) 9 (56.3) 25 (39.1) 
Correct 29 (74.4) 3 (33.3) 7 (43.8) 39 (60.9) 
Total 39 9 16 64 
 
Table 36: Correct Responses (%) by Number of Children – NF1 
 
 
No Children 1 Child 2 Children Total 
Wrong 19 (37.3) 7 (87.5) 2 (22.2) 28 (41.2) 
Correct 32 (62.8) 1 (12.5) 7 (77.8) 40 (58.8) 
Total 51 8 9 68 
 
  
Table 35 shows that for scenario 15 (NF1), residents with a biology/health 
undergraduate major had the highest correct response rate (74.4%). Interestingly, 
residents with a liberal arts major had a higher correct response rate than residents 
with a major in sciences other than biology (43.8% vs. 33.3%, respectively). Residents 
with one child had the lowest correct response rate (12.5%), while residents with two 
children had the highest (77.8%) as seen in Table 36.  
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Discussion 
 
 This study was undertaken to evaluate the baseline genetic testing knowledge 
among a selected group of pediatric residents in Houston, Texas. Similar to other 
studies of resident knowledge, we found that residents in these pediatric-focused 
residency programs had insufficient knowledge of first-tier genetic testing. The mean 
overall score was 43.0%, (maximum score of 80% and a minimum score of 0%), which 
was significantly lower than the expected mean overall score of 56.9% (p<0.00001).  
Additionally, the expected mean overall score was lower than 70%.  Since the 
importance of genetics in primary care is increasing, it is crucial that physicians are 
knowledgeable about genetic testing so that they can better serve their patients.  
 
 In the current study, several variables concerning genetics education affected 
overall percent score.   Perhaps these variables can be explored further to find 
innovative ways in which both medical school and residency programs curricula can be 
altered to improve baseline genetic testing knowledge. 
 
Variables Affecting Overall Score 
Not every resident answered all 15 case-based scenario questions, thus scores 
were compared for residents who answered only the first page and residents who 
completed the entire survey to determine if genetics knowledge differed for those five 
questions. As we did find a significant difference between these two groups of 
residents, we feel that the residents who stopped the survey early did so because 1) 
they felt the questions were too hard or 2) they had a lack of confidence in their ability 
and/or knowledge. Indeed, we found that the mean score on the first five questions for 
those residents who stopped after the first page was 24.4%, while the mean score on 
those same questions was 46.8% for those residents who finished all three pages 
(p=0.024). Furthermore, the overall observed correct score of 43.0% (regardless of 
number pages completed) might be an overestimate of this population’s genetics 
knowledge if the reason that some  residents stopped early was in fact due to lack of 
knowledge.  
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 The mean overall correct score was significantly lower for family practice 
residents. We speculate that a lack of genetics training is at least one reason 
explaining why these residents scored lower compared to residents from other 
programs. Family medicine residency curricula include more varied rotations (e.g. 
internal medicine, obstetrician/gynecology, surgery and sports medicine, etc.) and less 
time in pediatrics, [41], leaving less time for more specialized rotations such as 
genetics. In UT’s family practice residency program, a genetics rotation is not a 
requirement. The only genetics experience these residents receive is if they work with a 
genetic counselor and/or geneticist during their pediatric/neonatology rotation [55]. 
Thus, integrating more genetics training into these rotations is probably the best option 
for family medicine residency programs, as it is likely that they will encounter a baby 
with an underlying genetic condition while in their one short nursery rotation. 
 
 The mean overall correct score was significantly lower for residents who 
attended medical school abroad compared to those who graduated from medical 
schools in the United States. Nearly 86% of our population of foreign medical school 
graduates (12 of 15) was comprised of family practice residents. Given that family 
practice residents scored lowest overall, we contend that the low scores among foreign 
medical school graduates is more reflective of their residency  training than of where 
they attended medical school. Indeed, once residency specialty was accounted for, 
multivariate analysis showed that location of medical school training was no longer a 
significant predictor of overall score.  
 
The last variable that affected mean overall correct score was nature of the 
genetics rotation in medical school. Residents who elected to complete a genetics 
rotation in medical school scored significantly higher than those who did not undertake 
a genetics rotation. This is logical considering that residents who elected to complete 
such a rotation in their undergraduate medical education were probably interested in 
genetics and motivated to retain the information they learned. It should be noted that 
the question asking residents if their medical school required a genetics rotation 
caused confusion, as no medical schools in the United States are known to require its 
students to rotate through genetics. The misunderstanding of this question is further 
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evidenced by the fact that 4 residents who reported they attended medical school at UT 
indicated they were required to complete a genetics rotation while in medical school, 
when it is known that no such requisite exists at UT. Additional limitations of using a 
non-validated questionnaire for the study will be addressed later on. 
 
There were several variables that did not affect overall score. Of note, residents 
who reported that they seek out genetic information did not score higher than those 
who reported that they do not seek out such information. This finding is counterintuitive 
one would expect that individuals who seek out genetic information would perform 
better than those who do not because they are interested in the subject matter, 
motivated to learn, and may retain the information.  
 
Although residency year did not significantly affect the mean overall correct 
score, a trend was observed that residents at the end of their training scored higher 
than those in the beginning of their training.  This pattern is to be expected, as 
residents in later years of residency have more overall experience than those in their 
earlier years. First-year residents had completed 5 – 8 months of residency by the time 
the survey was administered.  The majority of their genetics knowledge would have 
largely been from their undergraduate medical education. In contrast, physicians in 
later years of residency may have had medical school genetics education in addition to 
specific genetics training in their residency programs, as well as years of genetics 
exposure through experience.  At UT, a two-week genetics rotation is now required for 
all categorical pediatric residents [56].  Pediatric Neurology residents at UT also 
complete this two-week genetics rotation since their residency program consists of the 
first two years of categorical pediatrics followed by additional requirements in child 
neurology [57]. Internal Medicine/Pediatrics residents at UT must now also complete a 
one-month genetics rotation in their fourth year [58], but the family practice residency 
program does require any genetics at all [59].  At BCM, genetics is not a required 
rotation for any specialty; it is integrated into residents’ curricula through a noon 
conference series and direct patient care [60].  
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When the individual scenarios were analyzed, we found certain topics that would 
benefit from additional instruction in both medical school and residency program 
curricula.  These topics include: 1. Clarification of the appropriate use of CMA in a 
genetics work-up, 2. Clarification of the role of karyotype in genetic diagnosis, and 3. 
Clinical actions in the event of a positive newborn screen. Each will be discussed 
separately.  
 
Appropriate Use of CMA in a Genetics Work-Up  
Since chromosomal microarray analysis (CMA) is a relatively new genetic 
testing technology, it was given as an answer choice for 13 of the 15 questions in the 
survey but was the correct answer for only one question: scenario 8 (multiple 
congenital anomalies). It is encouraging that the majority of responders correctly 
answered this question. However, there were several scenarios in which residents 
inappropriately selected CMA as the answer choice.  For the survey, there were two 
ways a CMA could be inappropriate for use in a clinical diagnosis. The first involved the 
use of CMA to detect single-gene disorders (e.g. Fragile X, Cystic fibrosis, Noonan, 
and achondroplasia). The second involved ordering a CMA in conjunction with another 
test when both tests give the same or similar information (i.e. redundant genetic 
testing). 
 
It is evident from scenario 2 (Fragile X) that residents do not understand that 
there are some genetic conditions CMA cannot detect. Participants were given both the 
suspected diagnosis as well as the type of causative mutation (trinucleotide repeat). 
However, the majority of respondents (65.2%) chose an answer choice including CMA. 
Even if residents did not specifically know the meaning of answer choice E, ‘Order 
Fragile X DNA testing,’ four of the five answer choices could have been eliminated as 
possibilities had they realized CMA cannot detect trinucleotide repeats. Additionally, 
when this question was analyzed using current genetic testing prices, residents spent 
an average of $2,000 more than was actually necessary to make the correct diagnosis. 
Perhaps genetics education for physicians should make it a priority to focus on the 
different types of mutations that cause genetic disease and the testing methodologies 
designed to detect them. Grouping genetic conditions by etiology (i.e. conditions 
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caused by chromosome aberrations, conditions caused by single genes) would be a 
helpful addition to medical school and pediatric-focused residency program curricula. If 
no effort is made to correct the deficit of knowledge shown by this survey, health care 
dollars will continue to be unnecessarily used. 
 
Similarly, scenario 14 asked residents to order testing helpful in the diagnosis of 
achondroplasia. Again, the suspected diagnosis was given for the question although 
the type of mutation was not. Nearly one-fourth (22%) of the responders incorrectly 
chose CMA, a testing modality that does not detect the two point mutations in FGFR3 
responsible for achondroplasia in 99% of affected individuals. More importantly, 
achondroplasia remains a clinical diagnosis and molecular testing is not usually 
indicated [61]. Molecular testing was not given as an option, and it would have been 
interesting to see how often it was chosen if it had been an answer choice. 
 
The Role of Karyotype in Genetic Diagnosis 
The clinical scenarios involving Down syndrome and Turner syndrome best 
illustrate that residents were not familiar with the correct role of karyotype in genetic 
diagnosis. Chromosome analysis via a routine karyotype is the only genetic test 
necessary to give a patient a diagnosis of Down syndrome or Turner syndrome. In 
addition to a diagnosis, accurate information on both etiology and recurrence risk are 
also obtained via karyotype. Almost 10% of residents chose CMA as the correct 
answer to scenario 3 (Down syndrome), an observation possibly attributed to the once-
common practice of ordering the test alongside karyotype when CMA first became 
clinically available.  
 
Also in scenario three, roughly half (50.7%) of respondents chose an answer 
involving FISH for chromosome 21. It is possible that these were popular answer 
choices simply because they were the only ones that made reference to chromosome 
21. Moreover, there could also be confusion since aneuploidy FISH is commonly used 
to diagnose chromosomal aneuploidies prenatally to facilitate timely decision-making 
during pregnancy.  Alternatively, residents might be unaware of both the limitations of 
FISH for chromosome 21 and the expensive nature of the technology. FISH for 
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chromosome 21 can certainly identify three copies of chromosome 21 in the vast 
majority of cases, but it cannot differentiate between free trisomy 21 and translocation 
21.  The difference between free and translocation trisomy 21 is essential in giving 
families correct recurrence risk information.  Additionally, FISH for chromosome 21 
costs several hundred dollars, when the cost of a routine karyotype is all that should be 
expended.  This extra expense is generally not justified when a non-lethal aneuploidy, 
such as Down syndrome, is suspected. 
 
While it is not outside the realm of possibilities that microarray technology, or 
something similar, will eventually be able to differentiate between Down syndrome 
caused by a translocation and Down syndrome caused by free trisomy 21, currently a 
karyotype gives the most complete information needed in a clinical setting. Additionally, 
at least one major clinical genetic testing laboratory has explored array technology for 
the detection of sex chromosome imbalances like Turner syndrome [62], although there 
remain limitations to sensitivity that should be resolved before CMA is ordered in place 
of a karyotype. 
 
Clinical Actions in the Event of a Positive Newborn Screen 
 Residents had the second lowest percent correct rate (6.9%) for the scenario 
involving a positive newborn screen for PKU. However, the score on the question is 
probably not an accurate assessment of residents’ knowledge for the following 
reasons. In the state of Texas, for a positive first newborn screen for PKU, plasma 
amino acids should be ordered in conjunction with a consultation and/or referral to a 
metabolic specialist [63].  In addition, a second newborn screen should be drawn, if it 
has not already been done.  The answer choice that the committee deemed correct 
was an immediate referral to a metabolic specialist, an answer that does not completely 
reflect recommended guidelines. Nearly half of all residents (47%) chose ‘switch the 
child to a low phenylalanine diet, order plasma amino acids, and repeat the newborn 
screen.’ While we initially chose immediate referral to a metabolic center as the correct 
choice, because the overall instructions for the survey state that all answers should be 
done in conjunction with a referral to a genetics specialist, this answer choice was 
redundant.  If used in future surveys, this particular scenario will need to be re-worded. 
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 It should be noted that the ACT Sheet, provided to physicians by the Texas 
Department of State Health Services in the event of a positive newborn screen for 
PKU, states that the child’s diet should not be changed until the second screen comes 
back positive.  Thus, the 68% of residents who selected one of the two answer choices 
that included switching their patient’s diet still answered incorrectly. For our survey, 
residents were provided space at the end to write comments about the survey and 
there were no comments about the question being particularly “tricky.” Respondents’ 
comments can be found in Appendix E. 
 
Variables Affecting Individual Questions 
As stated in the results, there were several variables that significantly affected 
the percent correct rate for individual scenario questions. When the observed correct 
answer rate for a particular scenario question was affected by one or two variables, it 
was likely an artifact of small sample size and not due to a true difference in genetic 
testing knowledge. Residency specialty significantly affected observed correct rate for 
several questions; however, this could be explained by the fact that family practice 
residents performed worse overall than residents from the other three programs. 
 
Possible Ways to Increase Genetic Testing Knowledge Among Primary Care 
Providers 
 
Acknowledging that genetics is a rapidly expanding field and that appropriate 
testing frequently changes, strategies should be developed to increase genetics 
knowledge and keep practicing physicians up-to-date in standard medical practice. 
Restructuring undergraduate medical education in genetics like Baylor College of 
Medicine (BCM) has done gives students the opportunity to begin learning about 
genetics and medicine simultaneously as early as possible. It would be illuminating to 
perform a study similar to this one comparing medical residents who completed a 
genetics track while in medical school to those that did not. In fact, BCM has such 
longitudinal studies planned for the future [45]. However, it is expected that only those 
medical students who choose to focus on genetics during medical school will have 
increased knowledge. 
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For students who do not choose a genetics track, supplemental education is 
needed from another source. Several studies of physicians have suggested that current 
genetics instruction is too focused on rare disorders and not focused enough on 
common conditions like high cholesterol [48]. To increase clinical relevance of genetics, 
it has been advocated that medical schools teach genetics in an integrated manner 
and/or teach genetics in a way that is clearly applicable to a particular clinical specialty 
[64,65]. Our data did not support the fact that integrated teaching was better for 
medical school genetics instruction, as residents who had a dedicated genetics class 
scored higher overall than those who had genetics integrated into their curricula. It 
should be noted however, that our data was only on the cusp of statistical significance 
and perhaps with a bigger study population, there might have been a different result  
 
Another way to increase knowledge regarding genetic testing could be to tailor 
clinical scenarios to particular trainees depending on their chosen specialty.  For 
example, autosomal dominant inheritance might be best taught to a cardiologist using 
Marfan syndrome as an example, while achondroplasia might be most useful for 
orthopedic trainees. But regardless of the chosen method and examples used, genetics 
education must extend from instruction about natural history and inheritance patterns to 
appropriate baseline clinical testing for these conditions (e.g. echocardiograms for 
suspected Marfan syndrome and skeletal surveys for suspected achondroplasia). 
 
Reigert-Johnson, et al. (2004) highlighted several potential areas of 
improvement for genetics education. A notable proposal was that residents be formally 
supervised by a member of a genetics department [66]. However, due to the paucity of 
genetics professionals in healthcare practice, it would be difficult to execute this idea 
[67]. Although it could be ideal, long new patient wait lists would prevent most clinical 
geneticists from entering into such agreements with primary care practices. An 
academic medical center would be better able to implement the suggestion, but even 
our clinical pediatric service at UT in the Texas Medical Center has found that such an 
agreement would be impossible given our high patient volume. Another potential 
solution provided by Reigert-Johnson, et al. is participation of medical geneticists in 
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Morbidity and Mortality (M&M) conferences, thus encouraging physicians to consider 
and appreciate the contribution of genetics to illness.  
 
Addressing deficits of genetics education in medical school and residency 
programs still leaves the very large population of practicing physicians who are no 
longer in residency but need to be kept current on rapidly changing genetic testing 
technology. To remedy the problem, credentialing should consider endorsing genetics-
focused CME opportunities.  
 
Other potential solutions exist to encourage PCPs to work collaboratively with 
medical geneticists and genetic counselors. Since we have established that medical 
geneticists likely do not have the time required to supervise residents in practice, these 
healthcare professionals could choose to mentor in other ways. At UT, medical 
geneticists and genetic counselors regularly give grand rounds presentations about 
genetics and genetic testing to attending and resident physicians on a variety of topics 
including genetic testing and newer technology such as Non-invasive Prenatal 
Diagnosis (NIPD). Given that genetic counselors are specifically trained to explain 
complex genetic concepts to individuals with varying knowledge bases, perhaps 
genetic counselors can invite their pediatrician colleagues to such presentations. Such 
multi-disciplinary collaboration would likely increase PCP knowledge and their 
understanding of the role genetics plays in disease.  
 
Building on the idea of multi-disciplinary collaboration, we propose that pediatric-
focused PCPs should consult their genetic-focused colleagues more when 
encountering a patient who could have an underlying genetic condition. Examples 
might include consulting with a geneticist or genetic counselor about appropriate first-
tier genetic testing to order or asking whether a child would benefit from a referral to a 
genetics specialist. Collaboration in hospitals or doctors’ offices when genetic testing is 
being ordered could potentially decrease the monetary burden of genetic services on 
the health care system. In addition, similar to ARUP, more laboratories could use 
genetic counselors to assess their testing requests to decrease duplicate or redundant 
genetic testing. Furthermore, LBJ General Hospital in Houston, TX is piloting a genetic 
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screening clinic program with certified genetic counselors evaluating children and their 
family histories to recommend appropriate genetic testing before the child has an 
appointment with the medical geneticist. The idea of a pediatric genetics screening 
clinic has the potential to help with both over-crowded genetics clinics and with 
reducing unnecessary genetic testing. 
 
Strengths and Limitations 
Our study is the first to focus on the current use of Chromosomal Microarray 
Analysis in primary care and has provided preliminary evidence that pediatrics-focused 
residents are aware of the test but do not understand its appropriate use. In addition, 
cost analysis was incorporated into our study. This was found to be a limitation to 
previous studies of physician knowledge of genetics [31]. 
 
We have examined the lack of genetics knowledge among health care providers 
in a novel way; however we acknowledge some limitations to our study. The limitations 
include self-reported data, small sample size (n=81) and use of a non-validated 
questionnaire. As mentioned previously, it appears that the demographic question 
regarding a required genetics rotation in medical school caused confusion, since 10 
residents indicated their medical schools required a genetics rotation. If this survey is 
used again in the future, this question will need to be reworded since there are no 
medical schools in the United States known to require such a rotation of its students. 
Repeating this study with greater number of residents and a validated survey tool 
would make the results more generalizable. Furthermore, we were not able to recruit 
family practice residents from BCM. If the BCM family practice residents had 
participated, the overall score of family practice residents may have been higher. 
However, it should be noted that medical school affiliation for residency programs did 
not significantly affect overall score for the other three specialties, so family practice 
residents from BCM may have performed poorly as well.  
 
We also acknowledge that the correct answer for each case-based scenario 
question was determined by a small number of practicing genetics professionals. While 
every effort was made to ensure that our determination of the correct answer was in 
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line with current guidelines and recommendations, we concede that standard of care is 
different among institutions.  
 
We anticipated that residents might use down time to answer the survey (i.e. 
answering the questions in an on-call room), so we had to enable multiple answers per 
computer to get the highest response rate. Additionally, although we asked residents to 
answer the questions from their own knowledge and not to consult any references, we 
cannot guarantee that they did not do so. Since residents had low genetic testing 
knowledge overall, we do not expect that any such collaboration would have 
significantly increased percent score overall.  
 
Future Directions 
A study of a larger group of residents who elected to take genetics in medical 
school to assess how they initially became interested in genetics could be enlightening. 
Such an analysis might highlight ways to increase the population of medical students 
who have an interest in genetics. Also, just as we have suggested that primary care 
physicians should collaborate more with genetics professionals, the genetics work force 
should make every effort to ensure that genetics resources are up-to-date. For 
example, ‘Genetic Testing 101’, an educational resource published by the National 
Coalition for Health Professional Education in Genetics, does not contain any 
information about array-CGH technology [68]. 
 
Conclusions 
In conclusion, the results of the current study supported our contention that 
pediatrics-focused are deficient in their knowledge about first-tier genetic testing as it 
pertains to clinical practice. While previous studies have focused on physician recall of 
genetic information, this study asked residents to apply what they knew about genetics 
to a clinically based scenario that they might encounter in practice and determine the 
most appropriate first-tier genetic testing needed.  
 
Additionally, we have provided preliminary evidence of possible excess health 
care spending in the course of diagnosing certain genetic conditions. This concept 
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should be explored further with future studies since health care costs in the United 
States continue to rise.  
 
Through this study, we identified several topics for clarification with regard to 
genetic testing that can be used in medical education: appropriate use of CMA in the 
genetics work-up, the role of karyotype in genetic diagnosis, and clinical actions to be 
taken in the event of an abnormal newborn screen.  
 
Several previously proposed remedies for addressing deficient health care 
provider genetics knowledge were also explored in the context of the results of this 
study. It is our hope that medical schools and residency programs continue to alter their 
curricula to make genetics education the most relevant it can be to clinical practice.  
Ultimately, strides must be taken to overcome this deficient in knowledge in first-tier 
genetic testing among pediatric-focused health care providers to ensure that families 
receive the best care possible in both a timely fashion and at a reasonable expense.  
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Appendix A – Demographic Questions and Survey 
 
Study Questionnaire – Demographic Information 
Demographics 
Please complete all of the following questions: 
Age:  ______________ 
Sex:            Male   Female 
Which residency specialty training program are you in currently? 
 Pediatrics 
 Combined Internal Medicine/Pediatrics 
 Pediatric Neurology 
 Family Practice 
 Other - please specify ___________________ 
In what year of residency are you currently? 
 1st 2nd 3rd 4th  
Are you post-call today?  Yes  No 
 
Undergraduate demographic questions 
 
Did you obtain an undergraduate degree before attending medical school?          
  Yes            No 
If yes: 
What was your undergraduate major? ________________________ 
What was your undergraduate minor? ________________________ 
If no, please describe your education prior to entering medical school:   
_________________________________________________________ 
Do you have any post-undergraduate degrees?   Yes  No 
If yes, which other degrees do you have? ___________________ 
How many genetic courses did you take in your undergraduate training?      
 0  1-2  3-4  5+ 
 
Medical school demographics questions 
  
Did you attend medical school in the United States?  Yes  No 
If Yes:       From which medical school did you graduate? ________________ 
               In which state is this medical school located?    ________________ 
If No:         From which medical school did you graduate? _________________ 
              In which country is this medical school located? _______________ 
How many genetic courses did you take in medical school? 
 0  1-2  3-4  5+ 
Did your medical school require a Genetics rotation?   Yes   No 
 If yes, how many weeks was your genetics rotation? ____________________ 
 If no, did you elect to complete a genetics rotation?  Yes  No 
  How many weeks was this elective genetics rotation? _______________ 
Do you have children?  Yes  No 
 If yes, how many? _________ 
 How many of your children are under the age of 5? ________ 
   66 
 
Have any of your children or family members been diagnosed with a genetic condition?
 Yes     No 
 If yes, what is the genetic condition? __________________________________ 
 
Other 
 
Have you ever taken a genetics class as an elective (i.e. not required by your degree 
program)?   Yes No 
 If yes,  how many?   1  2  3  4+ 
Do you subscribe to any scientific journals that are genetics-focused? Yes 
 No 
 If yes: to which genetics-focused journals do you subscribe? _______________ 
Do you seek out genetics information (i.e. news stories, T.V./movie documentaries, 
etc.)           Yes No 
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Genetic Testing Knowledge Survey 
Directions:  Please read each scenario and choose the single, best answer, looking 
for the most appropriate first tier genetic test/clinical action to consider when 
evaluating a patient with a potential underlying genetic condition.  This genetic 
test/clinical action should be in conjunction with a referral to a genetics 
specialist.   
 
1. A 39-week G2P1 female delivers a baby weighing 3,200 g and measuring 50 cm 
long. This baby appears male but is determined to have ambiguous genitalia with 
stretched penile length of about 2 cm. The gonads are not palpable. How would you 
proceed? 
A. Order Chromosomal Microarray Analysis (CMA) 
B. Order Chromosomal Microarray Analysis (CMA) + Karyotype 
C. Order Congenital Adrenal Hyperplasia (CAH) biochemical screen 
D. Order Congenital Adrenal Hyperplasia (CAH) biochemical 
screen + Karyotype 
E. Order Congenital Adrenal Hyperplasia (CAH) biochemical screen   
+ Karyotype + Chromosomal Microarray Analysis (CMA)  
 
2. You have been following a 6-year-old male in your clinic with a history of significant 
intellectual disability, autistic features, and dysmorphic features consistent with 
Fragile X syndrome. Fragile X syndrome, a common genetic cause of intellectual 
disability, is due to a trinucleotide (CGG) repeat in the FMR1 gene on the X 
chromosome. How would you proceed? 
 
A. Order Chromosomal Microarray Analysis (CMA) 
B. Order Chromosomal Microarray Analysis (CMA) + Fragile X testing 
C. Order Chromosomal Microarray Analysis (CMA) + Fragile X testing + karyotype 
D. Order Chromosomal Microarray Analysis (CMA) + karyotype 
E. Order Fragile X testing 
 
3. A full-term female baby is born to a G1P0 mother with Apgar scores of 9 and 10 at 1 
and 5 minutes respectively.  Upon examination, you note the baby has almond-
shaped eyes, epicanthal folds, a flattened face, and protruding tongue. You suspect 
this baby girl has Down syndrome. After talking to the mother, you learn that her 
sister also had a child with Down syndrome.  How would you proceed? 
 
A. Order Chromosomal Microarray Analysis (CMA) 
B. Order Fluorescence In-situ Hybridization (FISH) for chromosome 21 
C. Order a karyotype 
D. Order Chromosomal Microarray Analysis (CMA) + Fluorescence In-situ 
Hybridization (FISH) for chromosome 21 
E. Order Chromosomal Microarray Analysis (CMA) + Karyotype 
 
 
 
   68 
 
4. You follow a 3-month-old Caucasian baby with a history of failure to thrive. At birth, 
the baby had meconium ileus, and has since had a history of failure to thrive. 
Newborn screening for immunoreactive trypsinogen (IRT) was high and a sweat test 
was inconclusive. You suspect Cystic Fibrosis, which is caused by mutations in 
CFTR.  How would you proceed? 
 
A. Order CFTR deletion testing 
B. Order CFTR full sequencing to look for mutations in the gene  
C. Order CFTR common mutation panel to look for mutations in the gene 
D. Order Chromosomal Microarray Analysis (CMA) to look for absence or 
duplication of CFTR gene 
E. Order Chromosomal Microarray Analysis (CMA) + CFTR common mutation 
panel 
 
5. The maternal aunt of the baby in the previous question is starting to plan her family. 
Due to her nephew’s genetic testing and subsequent parental testing, she knows 
that her sister carries a deltaF508 mutation in one of her copies of the CFTR gene. 
She decides to pursue testing and discovers that she carries this mutation as well. 
Her husband is of Latino ancestry.  What is the most appropriate testing for him as 
he pursues carrier screening? 
 
A. CFTR deletion testing 
B. CFTR full sequencing to look for mutations in the gene  
C. Targeted CFTR mutation testing to see if he also carries the deltaF508 mutation 
D. CFTR common mutation panel to look for mutations in the gene 
E. Chromosomal Microarray Analysis (CMA) to look for absence or duplication of 
the CFTR gene 
 
6. The parents of one of your patients tell you they are concerned because their 10-
month-old daughter’s fingers have started trembling. You note that the baby can sit 
on her own but has generalized muscle weakness and absent tendon reflexes. You 
suspect the baby might have Spinal Muscular Atrophy (SMA), which is caused by 
mutations in SMN1.  How would you proceed? 
 
A. Order deletion/duplication testing of SMN1 to look for deletions & duplications 
B. Order Chromosomal microarray (CMA) to look for deletion or duplication of 
SMN1 
C. Order sequencing of all exons of SMN1  
D. Order sequencing of only exons 7 and 8 of SMN1 
E. Order targeted deletion analysis of exons 7 and 8 of SMN1 
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7. You see a 28-month-old boy as a new patient in your clinic that has developed 
severe hyperphagia. His mother tells you she has put locks on all cabinets 
containing food. His mother is very confused because when her son was a baby, he 
never liked to eat and even had a history of failure to thrive. His mother tells you that 
her son never does what she asks him to do and throws frequent temper tantrums. 
Upon examination, you note the child has a hypoplastic scrotum and cryptorchidism. 
You suspect this child might have Prader Willi syndrome, which is caused by 
mutations in SNRPN.  How would you proceed? 
 
A. Order Chromosomal Microarray Analysis (CMA) 
B. Order FISH for the Prader Willi critical region 
C. Order methylation studies of the Prader Willi critical region 
D. Order sequencing of SNRPN 
E. Order testing for uniparental disomy (UPD) of Prader Willi critical region 
 
8. You see a 3-year-old boy in your clinic as a new patient. This child has general 
dysmorphic features and multiple congenital anomalies that do not particularly match 
any one syndrome. He also has severe motor and developmental delay.  How would 
you proceed?   
 
A. Order Chromosomal Microarray Analysis (CMA) 
B. Order a karyotype 
C. Order fragile X testing 
D. Order a telomere FISH panel 
E. Order a metabolic work-up (plasma amino acids, urine organic acids, 
acylcarnitine profile) 
 
9. One of your adolescent patients, a 16-year-old girl, comes in with her mother for 
primary amennorhea. Physical exam reveals that this patient is below the 3rd 
percentile for height, has some hearing loss and preliminary labs reveal 
hypothyroidism. How would you proceed? 
 
A. Order Chromosomal Microarray Analysis (CMA) 
B. Order a karyotype 
C. Order a skeletal survey 
D. Order a metabolic work-up (plasma amino acids, urine organic acids, 
acylcarnitine profile) 
E. Order a telomere FISH panel 
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10. A 2-week-old baby girl comes to your clinic with one positive newborn screen for 
hyperphenylalaninemia suggestive of Phenylketouria (PKU).  PKU is caused by 
mutations in the gene for phenylalanine hydroxylase (PAH).  How would you 
proceed? 
A. Order plasma amino acids and serum phenylalanine hydroxylase levels 
B. Immediately refer the child to a metabolic center 
C. Order sequencing of the phenylalanine hydroxylase (PAH) gene and 
switch the child to a low phenylalanine diet.  
D. Repeat the newborn screen and switch the child to a low phenylalanine 
diet 
E. Switch the child to a low phenylalanine diet, order plasma amino acids, 
and repeat the newborn screen 
 
11. You are referred a new male patient whose family has just moved to Houston from 
out-of-town. This patient is below the 3rd percentile in height, has a VSD, and 
developmental delay. He also has a broad, webbed neck, apparently low-set 
nipples, an unusually shaped chest, and characteristic facies (low-set, posteriorly 
rotated ears with fleshy helicies, epicanthal folds, and ptosis). How would you 
proceed?  
 
A. Order Chromosomal Microarray Analysis (CMA)  
B. Order a karyotype for Noonan syndrome 
C. Order a karyotype for Turner syndrome 
D. Order molecular testing for Noonan syndrome  
E. Order molecular testing for Turner syndrome 
 
12. You see a 15-year-old male patient who has just moved here from Argentina. He is 
>97th percentile for height, has a high arched palate, long limbs, pectus excavatum. 
It is unknown whether he is shares some of these characteristics with other family 
members. How would you proceed? 
 
A. Order Chromosomal Microarray Analysis (CMA) 
B. Order an echocardiogram, ophthalmologic exam, homocysteine and 
methionine panel 
C. Order a metabolic workup (plasma amino acids, urine organic acids, 
acylcarnitine profile) 
D. Order an echocardiogram and ophthalmologic exam 
E. Order sequencing of the RET gene responsible for Multiple Endocrine Neoplasia 
type 2 
 
13. You see a 2-week-old baby in clinic whose newborn screen results and CBC are 
suggestive of a hemoglobinopathy. How would you proceed? 
A. Order Chromosomal Microarray Analysis (CMA) 
B. Order full sequencing of the FVIII and FIX genes responsible for Hemophilia  
types A and B 
C. Order full sequencing of the HBB gene responsible for sickle cell disease 
D. Order a hemoglobin electrophoresis if not already done 
E. Order sickledex analysis if not already done 
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14. You see a 10-month-old child for his well-child exam and you notice that he has 
fallen off the growth curve. On physical exam, he has rhizomelic (proximal) 
shortening of the limbs, frontal bossing and midface hypoplasia. You believe this 
child most likely has achondroplasia. How would you proceed? 
 
A. Order Chromosomal Microarray Analysis (CMA) 
B. Order a metabolic workup (plasma amino acids, urine organic acids, 
acylcarnitine profile) 
C. Order serum calcium levels 
D. Order a skeletal survey 
E. Order vitamin D studies 
 
15. A 4-year-old female new to your clinic presents with 20 café au lait (coffee colored) 
macules greater than or equal to 5 mm in diameter, most commonly on the trunk 
and least commonly on the head and neck. You notice she also has freckling under 
her arms, a speech impediment, is <5th percentile for height and >95th percentile for 
FOC. You suspect this child has neurofibromatosis. How would you proceed? 
 
A. Diagnose neurofibromatosis based on clinical criteria 
B. Diagnose neurofibromatosis after molecular testing comes back positive 
C. Diagnose neurofibromatosis after skin biopsy studies come back positive 
D. Order a Chromosomal Microarray Analysis (CMA)  
E. Order an echocardiogram  
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Appendix B – Cover Letter/Consent Form 
 
 
Dear participants, 
 
The purpose of this survey is to assess residents' baseline knowledge regarding 
diagnostic strategies for genetic diseases. This study is composed of 15 multiple 
choice, scenario-based questions which we hope will allow greater understanding of 
current knowledge regarding this topic. Space is available for additional comments 
should you find this necessary. 
 
Please complete the demographic data and then answer the short survey. Do not write 
any information on the survey which would identify you personally. Please complete the 
survey from your own knowledge offhand and please do not use any outside resources, 
including other healthcare professionals. 
 
Completion of this anonymous survey is voluntary and for research purposes only. No 
information will be associated with any individual participant. Your answers will not be 
available to any of your instructors or to your program director and will in no way be 
used to evaluate you in your program. Data will be analyzed in aggregate and 
presented as part of a thesis project at the University of Texas Graduate School of 
Biomedical Sciences at Houston. By completing and submitting this survey, you are 
implying consent to have your answers used and shared among collaborators for this 
study. There is no financial compensation for taking this survey. 
 
After the completion of my project, the answers to my questions will be made available 
to you, should you be interested. If you have questions or concerns, please contact 
Samantha Penney or Sarah Noblin, MS, CGC at 713-566-5938. 
 
Thank you again for your participation.  
 
Samantha Penney 
UT Genetic Counseling Student 
The University of Texas Graduate School of Biomedical Sciences at Houston 
Principle Investigator 
 
Sarah J. Noblin, MS, CGC 
Assistant Director, UT Genetic Counseling Program 
The University of Texas Health Science Center at Houston 
Department of Pediatrics 
Committee Chair 
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Appendix C – Test Pricing 
 
Test Price ($) 
CMA 1780 
Karyotype 740 
FISH for Chromosome 21 630 
Fragile X trinucleotide repeat analysis 390 
CAH screen 121.75 
Telomere FISH 1030 
Plasma Amino Acids 235 
Urine Organic Acids 253 
Acylcarnitine Profile 311 
Molecular testing for Noonan (PTPN11 sequencing) 1750 
Echocardiogram (does not include technical fees or 
interpretation) 
1700 
Ophthalmologic Exam 205 
RET sequencing 1380 
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Appendix D – Variables Tested for Significance 
 
 
Gender 
Residency specialty 
Residency year 
Med school affiliation 
Post-call 
Undergrad major 
Undergrad minor 
Any genetics in undergrad (Y/N) 
Med school in U.S. (Y/N) 
Number of children 
Children under 5 years 
Family history of genetic condition (Y/N) 
Set-up of genetics classes in medical school  (dedicated/integrated/not addressed) 
Required genetics rotation med school (Y/N) 
Year genetics was taken in med school 
Nature of genetics rotation (none/required/elective) 
Length of elective genetics rotation 
Number of genetics classes in college undergraduate 
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Appendix E – Free Response Comments About the Survey 
 
“too long” 
“I’d be fascinated to get feedback on how I did.” 
“I would like to know the answers when the study is done. That would be helpful and 
informative for my practice. Thanks! Great survey!” 
I would love to be able to get feedback on my responses.” 
“Too long” 
“It would be nice to have the answers to these questions!” 
“I probably got most of these wrong but I don’t believe in pan-CMAing people” 
 
 
